Market Overview

Impax Labs Enters Commercialization Deal with Perrigo

Related PRGO
Benzinga's Top Upgrades
Worst Performing Industries For July 21, 2016
Related IPXL
Benzinga's M&A Chatter for Tuesday June 21, 2016
8 Biggest Mid-Day Losers For Tuesday
Sam Isaly Swaps ' Health Care Stocks in Second Quarter (GuruFocus)

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.

Posted-In: News


Related Articles (IPXL + PRGO)

View Comments and Join the Discussion!